Value of selective upper tract cytology for recognition of upper tract tumors after treatment of superficial bladder cancer

International Journal of Urology

Volumn 10, Issue 5, 2003, Pages 243-246

  Göǧüş, Çaǧatay ^a,b   Baltaci, Sümer ^a   Şahinli, Savaş ^a   Türkölmez, Kadir ^a   Bedük, Yaşar ^a   Göǧüs, Orhan ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Bladder neoplasms; Carcinoma; Cytology; Transitional cell; Urine

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER DISEASE; CANCER CYTODIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CYSTOSCOPY; CYTOLOGY; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS UROGRAPHY; MALE; PRIORITY JOURNAL; RETROGRADE PYELOGRAPHY; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY;

ADULT; AGED; CARCINOMA; CYSTOSCOPY; CYTODIAGNOSIS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS; URINARY TRACT; URINE;

EID: 0037956045     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2003.00611.x     Document Type: Article

References (16)

1. Oldbring J, Glifberg I, Mikulowski P, Hellsten S. Carcinoma of the renal pelvis and ureter following bladder carcinoma. Frequency, risk factors and clinicopathological findings. J. Urol. 1989; 141: 1311-3.
2. Schwartz CB, Bekirov H, Melmon A. Urothelial tumors of upper tract following treatment of primary bladder transitional cell carcinoma. Urology 1992; 40: 509-11.
3. Hurle R, Losa A, Manzetti A, Lembo A. Upper urinary tract tumors developing after treatment of superficial bladder cancer. 7-year follow-up of 591 consecutive patients. Urology 1999; 53: 1144-8.
4. Cookson MS, Herr HW, Zhang Z, Soloway MS, Sogani PC, Fair WR. The treated natural history of high risk superficial bladder cancer: 15-year outcome. J. Urol. 1997; 158: 62-7.
5. Miller EB, Eure GR, Schellhammer PF. Upper tract transitional cell carcinoma following treatment of superficial bladder cancer with BCG. Urology 1993; 42: 26-30.
6. Rabbani F, Perrotti M, Russo P, Herr HW. Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance. J. Clin. Oncol. 2001; 19: 94-100.
7. Walzer Y, Soloway MS. Should the follow-up of patients with bladder cancer include routine excretory urography? J. Urol. 1983; 130: 672-3.
8. Sadek S, Soloway MS, Hook S, Civantos F. The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer. J. Urol. 1999; 161: 77-80.
9. Schwalb DA, Herr HW, Sogani PC, Russo P, Sheinfeld J, Fair WR. Upper tract disease following intravesical BCG for superficial bladder cancer: five year follow-up. J. Urol. 1992; 147: 273A.
10. Herr HW, Cookson MS, Soloway MS. Upper tract tumors in patients with primary bladder cancer followed for 15 years. J. Urol. 1996; 156: 1286-7.
11. Jackman SV, Potter SR, Regan F, Jarrett TW. Plain abdominal x-ray versus computed tomography screening: sensitivity for stone localization after nonenhanced (spiral) computed tomography. J. Urol. 2000; 164: 308-10.
12. Neri E, Boraschi P, Caramella D et al. MR virtual endoscopy of the upper urinary tract. AJR 2000; 175: 1697-702.
13. Bian Y, Ehya H, Bagley DH. Cytologic diagnosis of upper urinary tract neoplasms by ureteroscopic sampling. Acta Cytol. 1995; 39: 733-40.
14. Nielsen K, Ostri P. Primary tumors of the renal pelvis. Evaluation of clinical and pathological features in a consecutive series of 10 years. J. Urol. 1988; 140: 19-21.
15. Lodde M, Mian C, Wiener H, Haitel A, Pycha A, Marberger M. Detection of upper urinary tract transitional cell carcinoma with ImmunoCyt: a preliminary report. Urology 2001; 58: 362-6.
16. Leistenschneider W, Nagel R. Lavage cytology of the renal pelvis and ureter with special reference to tumors. J. Urol. 1980; 124: 597-600.